The role of 5HT1D-receptor agonists and magnesium in the treatment of migraine headache

被引：0
|
作者：
Alexander Mauskop
Jerome Goldstein
机构：
来源：
Current Pain and Headache Reports | 1997年 / 1卷 / 3期
关键词：
Migraine; Sumatriptan; Migraine Attack; Migraine Headache; Zolmitriptan;
D O I：
10.1007/BF02938172
中图分类号：
学科分类号：
摘要：
This article reviews two interesting topics in migraine treatment research. First, the effectiveness of sumatriptan is compared with that of the newer 5HT1D-agonists. Second, recent discoveries regarding the effect of magnesium on brain chemistry have yielcled evidence that this element may have a role in migraine. We offer our findings and opinion on this subject.
引用
收藏
页码：246 / 250
页数：4
相关论文
共 50 条
  • [21] Prescribing for migraine with the focus on selective 5HT1-receptor agonists: a pharmacy database analysis
    Truter, I.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (05) : 319 - 326
  • [22] Recent 5-HT1A receptor agonists
    Gurwitz, D
    DRUG DISCOVERY TODAY, 1999, 4 (03) : 142 - 143
  • [23] Exclusion of 5-HT1B and 5-HT1D serotonin receptor genes in migraine.
    Marttila, P
    Kallela, M
    Wessman, M
    Hartiala, J
    Färkkilä, M
    Kaprio, J
    Peltonen, L
    Palotie, A
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A460 - A460
  • [24] Eletriptan -: Serotonin 5-HT1B/1D receptor agonist for the acute treatment of migraine
    Burkiewicz, JS
    Chan, JD
    Alldredge, BK
    FORMULARY, 2000, 35 (02) : 129 - +
  • [25] CGRP Receptor Antagonists and 5-HT1F Receptor Agonist in the Treatment of Migraine
    Capi, Matilde
    De Angelis, Valerio
    De Bernardini, Donatella
    De Luca, Ottavia
    Cipolla, Fabiola
    Lionetto, Luana
    Simmaco, Maurizio
    Martelletti, Paolo
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
  • [26] Mechanisms of action of the 5-HT1B/1D receptor agonists
    Tepper, SJ
    Rapoport, AM
    Sheftell, FD
    ARCHIVES OF NEUROLOGY, 2002, 59 (07) : 1084 - 1088
  • [27] In vitro assessment of the vascular effects of 5-HT1D-receptor agonists: Relationships with 5-HT1D alpha- or 5-HT1D beta-receptor binding affinity
    Shaw, D
    Stanton, JA
    Heald, MA
    Beer, MS
    Sternfeld, F
    Street, L
    Hill, RG
    Cooke, E
    Longmore, J
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 119 : P112 - P112
  • [28] Consensus statement:: Cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine
    Dodick, D
    Lipton, RB
    Martin, V
    Papademetriou, V
    Rosamond, W
    MaassenVanDenBrink, A
    Loutfi, H
    Welch, KM
    Goadsby, PJ
    Hahn, S
    Hutchinson, S
    Matchar, D
    Silberstein, S
    Smith, TR
    Purdy, RA
    Saiers, J
    HEADACHE, 2004, 44 (05): : 414 - 425
  • [29] The effects of 5-HT1A, 5-HT1B and 5-HT1D receptor agonists on trigeminal nociceptive neurotransmission in anaesthetized rats
    Cumberbatch, MJ
    Hill, RG
    Hargreaves, RJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1998, 362 (01) : 43 - 46
  • [30] Amerge -: 5-HT1 receptor agonist for acute treatment of migraine attacks
    不详
    FORMULARY, 1998, 33 (04) : 280 - 280
12345